Novo Nordisk Fonden har uddelt i alt 51 bevillinger til projektstøtte i Biovidenskab og Basal Biomedicin. Heraf har hele seks forskere fra MBG fået en bevilling.

06.12.2018 | Lisbeth Heilesen

Følgende forskere fra Institut for Molekylærbiologi og Genetik har fået en bevilling:

• Lektor Anni Hangaard Andersen
  Novel strategies for improvement of topoisomerase based cancer chemotherapy with camptothecin derivatives
  Kr. 1.373.000 
• Lektor Birgitta Knudsen
  Regulation and Function of G-quadruplex DNA Structures in Promoters of Human Proto-oncogenes
  Kr. 1.500.000
• Professor Gregers Rom Andersen
  Structure determination of antibodies and their complexes with electron microscopy
  Kr. 1.800.000
• Lektor Kim Hebelstrup
  Priming for flooding/hypoxic stress: The mechanism behind hemoglobin and ethylene action
  Kr. 2.100.000
• Professor Poul Nissen
  Structure determination of the human glycine transporter hGlyT1
  Kr. 1.568.420
• Lektor Simona Radutoiu og adjunkt Kasper Røjkjær Andersen
  Identifying functional determinants of specificity in receptor kinases signaling
  Kr. 2.992.737

---

Se listen over alle bevillinger fra Novo Nordisk Fondens program for Biovidenskab og Basal Biomedicin.

---